IL6 and rheumatoid arthritis: IL-6 activates inflammatory cells to enter the synovial membrane and propagate the inflammatory response (5), so inhibition of IL-6/IL-17A can potentially reduce joint inflammation and cartilage destruction of RA onset (6).